GREY:DGCRF - Post by User
Comment by
CUR2004on Aug 26, 2011 3:35pm
361 Views
Post# 18984068
RE: Cur +
RE: Cur +This is not $5.1M/year...this is about $1M/year minimum for 5 years plus $5.7M
in upfront payment for the acquisition of DiagnoCure’s U.S. laboratory.
For the US$2.5M R&D agreement I don't know how they will receive it. 500k per year?
So I don't think they will be profitable for the next 2-3 quarter but with US sales of PCA3 and after the $59M cumulative sales Diagnocure will receive 16% of royalties and we should be profitable at this time.
I think cumulative sales of Gen-Probe were about $30M at last General Meeting in march.